Bingqing Hui

1.4k total citations
22 papers, 953 citations indexed

About

Bingqing Hui is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Bingqing Hui has authored 22 papers receiving a total of 953 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 12 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Bingqing Hui's work include Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (6 papers) and RNA modifications and cancer (6 papers). Bingqing Hui is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (6 papers) and RNA modifications and cancer (6 papers). Bingqing Hui collaborates with scholars based in China, United States and Sweden. Bingqing Hui's co-authors include Hao Ji, Zhonghua Ma, Yetao Xu, Ke‐Ming Wang, Weiwei Tang, Xuezhi He, Yan Zhou, Lu Chen, Jirong Wang and Yun Tian and has published in prestigious journals such as Journal of Cellular Physiology, Molecular Therapy and Cell Death and Disease.

In The Last Decade

Bingqing Hui

22 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bingqing Hui China	20	627	612	203	116	107	22	953
Chi Lam Au Yeung United States	7	913 1.5×	758 1.2×	214 1.1×	135 1.2×	56 0.5×	15	1.2k
Francesca Fanini Italy	14	882 1.4×	716 1.2×	159 0.8×	120 1.0×	36 0.3×	25	1.1k
Xia Xu China	13	496 0.8×	449 0.7×	174 0.9×	53 0.5×	42 0.4×	20	712
Woo Young Kim South Korea	19	365 0.6×	314 0.5×	110 0.5×	104 0.9×	164 1.5×	41	920
Barbara Kinga Barták Hungary	18	589 0.9×	522 0.9×	239 1.2×	29 0.3×	54 0.5×	44	890
Mihaela Chivu‐Economescu Romania	14	463 0.7×	323 0.5×	249 1.2×	124 1.1×	149 1.4×	31	891
Petra Vychytilova‐Faltejskova Czechia	18	832 1.3×	796 1.3×	204 1.0×	41 0.4×	83 0.8×	31	1.1k
Giuseppina Della Vittoria Scarpati Italy	15	438 0.7×	313 0.5×	407 2.0×	116 1.0×	125 1.2×	44	973
Rong‐Miao Zhou China	19	459 0.7×	231 0.4×	294 1.4×	147 1.3×	87 0.8×	61	868

Countries citing papers authored by Bingqing Hui

Since Specialization

Citations

This map shows the geographic impact of Bingqing Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingqing Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingqing Hui more than expected).

Fields of papers citing papers by Bingqing Hui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingqing Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingqing Hui. The network helps show where Bingqing Hui may publish in the future.

Co-authorship network of co-authors of Bingqing Hui

This figure shows the co-authorship network connecting the top 25 collaborators of Bingqing Hui. A scholar is included among the top collaborators of Bingqing Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingqing Hui. Bingqing Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hui, Bingqing, Yetao Xu, Rui Wang, et al.. (2024). Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085. Journal of Nanobiotechnology. 22(1). 62–62. 25 indexed citations

Chen, Xiaofeng, Xiang Xu, Danping Wang, et al.. (2023). Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial. Journal for ImmunoTherapy of Cancer. 11(2). e005830–e005830. 54 indexed citations

Xu, Yetao, Dan Wu, Bingqing Hui, et al.. (2022). A novel regulatory mechanism network mediated by lncRNA TUG1 that induces the impairment of spiral artery remodeling in preeclampsia. Molecular Therapy. 30(4). 1692–1705. 23 indexed citations

Hui, Bingqing, Lü Chen, Haiyang Li, et al.. (2022). Inhibition of APOE potentiates immune checkpoint therapy for cancer. International Journal of Biological Sciences. 18(14). 5230–5240. 23 indexed citations

Li, Xiaofei, Mingjie Lu, Jing Ye, et al.. (2022). CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy. OncoImmunology. 11(1). 2118210–2118210. 54 indexed citations

Chen, Lu, Dawei Rong, Bingqing Hui, et al.. (2021). CircETFA upregulates CCL5 by sponging miR-612 and recruiting EIF4A3 to promote hepatocellular carcinoma. Cell Death Discovery. 7(1). 321–321. 23 indexed citations

Wang, Danping, Zhiying Zheng, Xinyang Liu, et al.. (2021). Current Perspectives on B Lymphocytes in the Immunobiology of Hepatocellular Carcinoma. Frontiers in Oncology. 11. 647854–647854. 26 indexed citations

Li, Zhitao, Wubin Zheng, Hanjin Wang, et al.. (2021). Application of Animal Models in Cancer Research: Recent Progress and Future Prospects. Cancer Management and Research. Volume 13. 2455–2475. 70 indexed citations

Hui, Bingqing, Lu Chen, Jing Wang, et al.. (2021). Engineered exosomes for co‐delivery of PGM5‐AS1 and oxaliplatin to reverse drug resistance in colon cancer. Journal of Cellular Physiology. 237(1). 911–933. 64 indexed citations

10.

Fu, Kai, Bingqing Hui, Qian Wang, et al.. (2020). Single-cell RNA sequencing of immune cells in gastric cancer patients. Aging. 12(3). 2747–2763. 39 indexed citations

11.

Chen, Lu, Wei Jiang, Bingqing Hui, et al.. (2019). The circ_0021977/miR‐10b‐5p/P21 and P53 regulatory axis suppresses proliferation, migration, and invasion in colorectal cancer. Journal of Cellular Physiology. 235(3). 2273–2285. 42 indexed citations

12.

Wu, Dan, Nana Yang, Yetao Xu, et al.. (2019). lncRNA HIF1A Antisense RNA 2 Modulates Trophoblast Cell Invasion and Proliferation through Upregulating PHLDA1 Expression. Molecular Therapy — Nucleic Acids. 16. 605–615. 28 indexed citations

13.

Hui, Bingqing, Hao Ji, Yetao Xu, et al.. (2019). RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4. Cell Death and Disease. 10(3). 207–207. 86 indexed citations

14.

Ma, Zhonghua, Peng Peng, Jing Zhou, et al.. (2018). Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer. Cellular Physiology and Biochemistry. 46(6). 2197–2214. 29 indexed citations

15.

Ji, Hao, Bingqing Hui, Jirong Wang, et al.. (2018). Long noncoding RNA MAPKAPK5‐AS1 promotes colorectal cancer proliferation by partly silencing p21 expression. Cancer Science. 110(1). 72–85. 30 indexed citations

16.

Ma, Zhonghua, Shengying Gu, Min Sup Song, et al.. (2017). Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer. Molecular BioSystems. 13(11). 2350–2361. 60 indexed citations

17.

Ji, Hao, Juan Li, Haiyan Wang, et al.. (2017). Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression. Cell Death and Disease. 8(8). e2997–e2997. 127 indexed citations

18.

Ma, Zhonghua, Hesuyuan Huang, Yetao Xu, et al.. (2017). Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors. OncoTargets and Therapy. Volume 10. 4711–4717. 34 indexed citations

19.

Lian, Yifan, Changsheng Yan, Hao Ji, et al.. (2017). A novel lncRNA, LL22NC03-N64E9.1, represses KLF2 transcription through binding with EZH2 in colorectal cancer. Oncotarget. 8(35). 59435–59445. 17 indexed citations

20.

Ma, Zhonghua, Hesuyuan Huang, Jirong Wang, et al.. (2017). Long non-coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2-mediated H3K27me3. Oncotarget. 8(48). 84153–84167. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact